Comments
Pharma major Lupin has received tentative approval for its Abacavir Sulfate (600 mg/300 mg) and Lamivudine tablets from the USFDA to market a generic version of ViiV Healthcare Company’s Epzicom tablets.
Epzicom tablets had US sales of $426 million. Lupin holds global leadership position in the anti-TB segment.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.